Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- Being enrolled in Golestan Cohort Study~Exclusion Criteria:~* Debilitating disease causing inability to comply~* Contraindications to any of the components of PolyPill~* Not consenting to the study

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Polypill (Type: EXPERIMENTAL): Single daily dose of PolyPill and 6-monthly visits
- Control (Type: NO_INTERVENTION): Only 6-monthly visits

Based on this trial design, predict the completion outcome and termination type (if applicable).